France						                            
                            
						
 Research Article
												Resistance to Co-Amoxiclav (Augmentin) in Community-Acquired and Nosocomial Pleural Infections 						
Author(s): Sébastien Champion and Marianne AnnonaySébastien Champion and Marianne Annonay             
						
												
				 Objective: To describe the ecology in pleural infections, where nosocomial and community-acquired infections may have different ecology.
Methods: retrospective single center study. Any subject admitted in intensive care unit with a diagnosis of complicated pleural effusion (presence of macroscopic pus, or sero-fibrinous pleural effusion with pH <7.2 or LDH >1000 or pleural glucose <0, 4 g/L, and signs of infection or positive bacteriological sampling) were included.
Results: From 2006 to 2012, 57 patients were included. Four strains of “Multi-resistant” bacteria were reported in 3 patients with community-acquired pleural infection. As a whole 3 out of 57 (5%) patients had microorganisms (not including candida and mycobacteria) resistant to co-amoxiclav. It was not different between nosocomial and community-acqu.. Read More»
				  
												DOI:
												 10.4172/2161-105X.1000284 
																	  
Pulmonary & Respiratory Medicine received 1690 citations as per Google Scholar report